SRNE

Sorrento Therapeutics, Inc.
SRNE

Overview Fund Activity
Delisted

SRNE was delisted on the 22nd of February, 2023.

Back to rankings

73 hedge funds and large institutions have $121M invested in Sorrento Therapeutics, Inc. in 2018 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
+27
Holders Change %
+58.7%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
32
Increased
25
Reduced
11
Closed
5
Calls
$1.04M
Puts
$1.67M
Net Calls
-$626K
Net Calls Change
-$704K

Top Buyers

1
State Street
State Street
Massachusetts
+$26.5M
2
BlackRock
BlackRock
New York
+$6.28M
3
Renaissance Technologies
Renaissance Technologies
New York
+$4.62M
4
Deutsche Bank
Deutsche Bank
Germany
+$4.31M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.57M

Top Sellers

1
WCM
Wildcat Capital Management
New York
-$6.81M
2
IP
Intellectus Partners
California
-$917K
3
OAM
Oxford Asset Management
United Kingdom
-$835K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$325K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$259K
Name Holding Trade Value Shares
Change 		Shares
Change %
Simplex Trading
76
Simplex Trading
Illinois
– -$57K -15,107 Closed
PAM
77
Pegasus Asset Management
New York
– -$57K -15,000 Closed
MIM
78
Monashee Investment Management
Massachusetts
– -$119K – –
1 2 3
4